The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2. (Q35236379)

7 August 2017

The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2. (English)

1 reference

7 August 2017

1 reference

13

Thomas Kariuki

1 reference

7 August 2017

Lázaro Gil

1

1 reference

7 August 2017

Ernesto Marcos

2

1 reference

7 August 2017

Alienys Izquierdo

3

1 reference

7 August 2017

Laura Lazo

4

1 reference

7 August 2017

Iris Valdés

5

1 reference

7 August 2017

Peris Ambala

6

1 reference

7 August 2017

Lucy Ochola

7

1 reference

7 August 2017

Rikoi Hitler

8

1 reference

7 August 2017

Edith Suzarte

9

1 reference

7 August 2017

Mayling Álvarez

10

1 reference

7 August 2017

Prisilla Kimiti

11

1 reference

7 August 2017

James Ndung'u

12

1 reference

7 August 2017

María Guadalupe Guzmán

14

1 reference

7 August 2017

Gerardo Guillén

15

1 reference

7 August 2017

Lisset Hermida

16

1 reference

7 August 2017

2 September 2014

1 reference

Immunology & Cell Biology

7 August 2017

1 reference

7 August 2017

93

1 reference

7 August 2017

1

1 reference

7 August 2017

57-66

1 reference

Update on the global spread of dengue

7 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Fatal dengue hemorrhagic fever in Cuba, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Primary and Secondary Infections of Macaca fascicularis Monkeys with Asian and American Genotypes of Dengue Virus 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

An in-depth analysis of original antigenic sin in dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2014.63

Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic.

21 January 2018

1 reference

12 December 2020

CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy

1 reference

12 December 2020

Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization

1 reference

12 December 2020

Efficacy of tetravalent dengue vaccine in Thai schoolchildren

1 reference

12 December 2020

Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii

1 reference

12 December 2020

Cost of dengue cases in eight countries in the Americas and Asia: a prospective study.

1 reference

12 December 2020

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

12 December 2020

Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses

1 reference

12 December 2020

Identifiers

DOI

10.1038/ICB.2014.63

1 reference

release_yhftnrlobnbvxpz4ns7apxcuty

7 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yhftnrlobnbvxpz4ns7apxcuty

24 November 2022

mapped directly with Wikidata item

1 reference